Enter your keyword(s) (company name, disease target, therapeutic category, industry sector) into the search box and hit the search button to return reports matching your interests.
Searches on wide topic areas may take a moment to display, please be patient. If you have any queries about the report searching please contact us.
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there...
Plunkett's Health Care Technologies Overview 2010 (Summary)
This summary contains the complete technologies section excerpted from the highly-acclaimed Plunkett's Health Care Industry Almanac. This report will be your ready-reference guide to new and developing health care technologies. Technology topics range from stem cells, to new drug delivery systems, to gene therapies. The report includes several statistical tables. You'll find the information you...
Japanese Market for Women's Health Devices 2009
The Japanese Market for Women’s Health Devices includes the markets for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, assisted reproduction, endometrial resection devices, hysteroscopes, colposcopes, female urinary incontinence slings, pelvic reconstruction devices and developing markets.
Worldwide Biotech - November 2009
Worldwide Biotech provides news and information on
biotechnology as an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.
Freedonia Focus on Biologicals
This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment, product and market forecasts, industry composition and leading participants. Product segments include recombinant proteins, monoclonal...
| GlaxoSmithKline | Pfizer |
| Merck & Co | AstraZeneca |
| Johnson & Johnson | Aventis |
| Bristol-Myers Squibb | Novartis |
| Pharmacia | Wyeth |
| Roche | Takeda Chemical Industries |
| Bayer |